SPROUT PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 17238
 
  
 
C07D HETEROCYCLIC COMPOUNDS 7155
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 346
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9782403 Treating sexual desire disorders with flibanserinSep 20, 16Oct 10, 17[A61K]
9763936 Flibanserin for the treatment of urinary incontinence and related diseasesJul 27, 15Sep 19, 17[A61K]
9730927 Use of flibanserin in the treatment of obesityNov 13, 15Aug 15, 17[A61K]
9546141 SaltsSep 12, 14Jan 17, 17[A61K, C07D, C07C]
9468639 Treating sexual desire disorders with flibanserinMar 06, 15Oct 18, 16[A61K]
8785458 Use of flibanserin in the treatment of obesityJul 16, 12Jul 22, 14[A61K]
8722682 Sulfated benzimidazolone derivatives having mixed serotonin receptor affinityDec 18, 07May 13, 14[A61K, C07D]
8227471 Treating sexual desire disorders with flibanserinSep 21, 06Jul 24, 12[A61K]
8227476 Use of flibanserin in the treatment of obesityJul 31, 06Jul 24, 12[A61K]
7923449 Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disordersOct 25, 06Apr 12, 11[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0111,898 Method for the treatment of premenstrual and other female sexual disordersAbandonedSep 03, 14Apr 23, 15[A61K]
2015/0072,994 Use of Flibanserin in the Treatment of ObesityAbandonedJul 21, 14Mar 12, 15[A61K]
2015/0011,564 Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor AffinityAbandonedMay 08, 14Jan 08, 15[C07D]
2015/0005,316 USE OF A POLYMORPH OF FLIBANSERIN FOR TREATING DISEASEAbandonedMay 05, 14Jan 01, 15[C07D]
2014/0329,827 Use of flibanserin for the treatment of pre-menopausal sexual desire disordersAbandonedMar 04, 14Nov 06, 14[A61K]
2014/0005,203 Treatment of Vasomotor SymptomsAbandonedMar 20, 13Jan 02, 14[A61K]
2013/0225,604 Use of flibanserin for the treatment of pre-menopausal sexual desire disordersAbandonedNov 13, 12Aug 29, 13[A61K]
2013/0209,519 FORMULATIONS OF FLIBANSERINAbandonedOct 22, 12Aug 15, 13[A61K]
2013/0203,671 Flibanserin for the Treatment of Urinary Incontinence and Related DiseasesAbandonedNov 19, 12Aug 08, 13[A61K]
2013/0203,766 Pharmaceutical Compositions for the Treatment of Sexual Disorders IIAbandonedOct 18, 12Aug 08, 13[A61K]
2013/0197,010 Use of Flibanserin for the Treatment of Sexual Disorders in FemalesAbandonedNov 08, 12Aug 01, 13[A61K]
2013/0190,326 Use of flibanserin for the treatment of post-menopausal sexual desire disordersAbandonedNov 12, 12Jul 25, 13[A61K]
2013/0172,304 Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual DisordersAbandonedJan 24, 13Jul 04, 13[A61K]
2013/0079,356 Method for the treatment of premenstrual and other female sexual disordersAbandonedJul 27, 12Mar 28, 13[A61K]
2012/0322,810 NEW SALTSAbandonedDec 14, 09Dec 20, 12[A61K, C07D, A61P]
2012/0270,883 USE OF A POLYMORPH OF FLIBANSERIN FOR TREATING DISEASEAbandonedJul 03, 12Oct 25, 12[A61K, A61P]
2012/0035,185 Method of Using Flibanserin for NeuroprotectionAbandonedOct 19, 11Feb 09, 12[A61K, A61P]
2011/0136,825 Treatment of Vasomotor SymptomsAbandonedSep 11, 08Jun 09, 11[A61K, A61P]
2011/0105,519 Pharmaceutical Compositions for the Treatment of Sexual Disorders IIAbandonedJan 10, 11May 05, 11[A61K, A61P]
2011/0045,090 FORMULATIONS OF FLIBANSERINAbandonedFeb 11, 09Feb 24, 11[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.